CIM
IDYA icon

Contravisory Investment Management’s IDEAYA Biosciences IDYA Stock Holding History

Contravisory Investment Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,183
Closed -$273K – 416
2026
Q1 		$273K Hold
8,183
– – 0.06% 184
2025
Q4 		$283K Buy
+8,183
New +$261K 0.06% 195

Other funds holding IDYA

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
KFP
Kerr Financial Planning Fresno, California $89.6M AUM 72.71% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Contravisory Investment Management's IDYA Position: Q2 2026 in Review

Contravisory Investment Management sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 8,183 shares — an estimated $273K sold.

Contravisory Investment Management first reported a position in IDYA in Q4 2025 and held it in 2 quarters. The position peaked at $283K in Q4 2025. 16 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Contravisory Investment Management reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Contravisory Investment Management sold 8,183 IDEAYA Biosciences shares in Q2 2026, an estimated $273K.
  • Contravisory Investment Management first reported a position in IDEAYA Biosciences in Q4 2025 and held it in 2 quarters.
  • Contravisory Investment Management's IDEAYA Biosciences position peaked at $283K in Q4 2025.
  • 16 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.